PD-1 and PD-L1 Expression in HER2-Positive Breast Carcinomas

被引：0
|
作者：
Ubago, Julianne M. [1 ]
Larson, Alexandra [1 ]
Eghtesad, Mansooreh [1 ]
Blanco, Luis Z. [1 ]
Pincus, Jennifer [1 ]
Siziopikou, Kalliopi P. [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
289
引用
收藏
页码：75A / 75A
页数：1
相关论文
共 50 条
  • [1] PD-1 and PD-L1 Expression in HER2-Positive Breast Carcinomas
    Ubago, Julianne M.
    Larson, Alexandra
    Eghtesad, Mansooreh
    Blanco, Luis Z.
    Pincus, Jennifer
    Siziopikou, Kalliopi P.
    MODERN PATHOLOGY, 2017, 30 : 75A - 75A
  • [2] Microsatellite Instability and PD-1/PD-L1 Expression in HER2-Positive Breast Carcinoma
    Ubago, Julianne M.
    Larson, Alexandra
    Rosen, Lauren
    Novo, Jorge
    Pincus, Jennifer
    Blanco, Luis
    Siziopikou, K. P.
    LABORATORY INVESTIGATION, 2018, 98 : 111 - 111
  • [3] Microsatellite Instability and PD-1/PD-L1 Expression in HER2-Positive Breast Carcinoma
    Ubago, Julianne M.
    Larson, Alexandra
    Rosen, Lauren
    Novo, Jorge
    Pincus, Jennifer
    Blanco, Luis
    Siziopikou, K. P.
    MODERN PATHOLOGY, 2018, 31 : 111 - 111
  • [4] The Immune Microenvironment of HER2 Positive Breast Carcinomas; CTLA-4 Expression and the PD-1/PD-L1 Axis
    Rosen, Lauren
    Novo, Jorge
    Ubago, Julianne M.
    Pincus, Jennifer
    Blanco, Luis
    Siziopikou, K. P.
    MODERN PATHOLOGY, 2018, 31 : 100 - 100
  • [5] The Immune Microenvironment of HER2 Positive Breast Carcinomas; CTLA-4 Expression and the PD-1/PD-L1 Axis
    Rosen, Lauren
    Novo, Jorge
    Ubago, Julianne M.
    Pincus, Jennifer
    Blanco, Luis
    Siziopikou, K. P.
    LABORATORY INVESTIGATION, 2018, 98 : 100 - 100
  • [6] Clinicopathological values of PD-L1 expression in HER2-positive breast cancer
    Sasagu Kurozumi
    Kenichi Inoue
    Hiroshi Matsumoto
    Takaaki Fujii
    Jun Horiguchi
    Tetsunari Oyama
    Masafumi Kurosumi
    Ken Shirabe
    Scientific Reports, 9
  • [7] Clinicopathological values of PD-L1 expression in HER2-positive breast cancer
    Kurozumi, Sasagu
    Inoue, Kenichi
    Matsumoto, Hiroshi
    Fujii, Takaaki
    Horiguchi, Jun
    Oyama, Tetsunari
    Kurosumi, Masafumi
    Shirabe, Ken
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [8] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [9] PD-1 and PD-L1 expression in neuroendocrine carcinomas of bladder
    Erdogan, S.
    Acikalin, A.
    Bagir, E. Kilic
    Inceman, M.
    VIRCHOWS ARCHIV, 2020, 477 : S159 - S159
  • [10] Progress of PD-1/PD-L1 inhibitor combination therapy in immune treatment for HER2-positive tumors
    Sining Zhao
    Yiwu Qiu
    Meiqin Yuan
    Zeng Wang
    European Journal of Clinical Pharmacology, 2024, 80 : 625 - 638
12345